机译:Aspidodasycarpine,Lonicerine和Lanciferine拟议结构的不对称总合成
State Key Laboratory of Bioorganic and Natural Products Chemistry, Collaborative Innovation Center of Chemistry for Life Sciences, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China,Zhejiang Key Laboratory of Alternative Technologies for Fine Chemicals Process, Shaoxing University, Shaoxing 312000, China;
State Key Laboratory of Bioorganic and Natural Products Chemistry, Collaborative Innovation Center of Chemistry for Life Sciences, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China;
State Key Laboratory of Bioorganic and Natural Products Chemistry, Collaborative Innovation Center of Chemistry for Life Sciences, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China;
State Key Laboratory of Bioorganic and Natural Products Chemistry, Collaborative Innovation Center of Chemistry for Life Sciences, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China;
机译:基于拟议结构的基质控制的微cladenlenesA,B和C的不对称全合成
机译:(+) - 茎氨基磷脂的总合成及其溶液-13(14)-118-醇和茎-13(14) - 17-乙酰氧基-18-OL的所提出的结构
机译:(-)-versiquinazoline H的拟议结构和修订结构的简洁,对映选择性全合成
机译:比较现有和建议的SOI MOSFET器件结构以最大程度地减少总剂量辐射损伤
机译:微管稳定剂laulimalide的全合成和细胞毒性大环内酯iriomoteolide-1a和-1b拟议结构的总合成。
机译:用萜烯醇部分控制不对称联芳构象:新对映纯C的合成结构和能量2-对称二醇
机译:Nhatrangin A:所提出的结构和六个非对映异构体的总合成